We examined anemia and malaria as risk factors for Kaposi sarcoma-associated herpesvirus (KSHV) seropositivity and antibody levels in a long-standing rural Ugandan cohort, in which KSHV is prevalent. Samples from 4134 children, aged 1-17 years, with a sex ratio of 1:1, and 3149 adults aged 18-103 years, 41% of whom were males, were analyzed. Among children, malaria infection was associated with higher KSHV prevalence (61% vs 41% prevalence among malaria infected and uninfected, respectively); malaria was not assessed in adults. Additionally, lower hemoglobin level was associated with an increased prevalence of KSHV seropositivity, both in children and in adults.
We recently reported Kaposi sarcoma-associated herpesvirus (KSHV) prevalence of 95% among adults in a rural population cohort (the General Population Cohort [GPC] in Uganda [1] ), the highest prevalence of KSHV ever reported, in addition to high KSHV antibody levels. We propose that the very high prevalence in this population may be driven by frequent KSHV reactivation, viral shedding, and transmission rates and that the high antibody levels also reflect frequent reactivation. It is important, therefore, to study potential cofactors for reactivation in relation to KSHV prevalence and antibody levels. We have previously reported an association between malaria and hookworm infections and KSHV seropositivity in an urban population in Uganda [2, 3] . Because both malaria and hookworm are associated with anemia, we hypothesized that anemia may have a role in KSHV transmission via viral reactivation. This hypothesis is supported by data from in vitro experiments showing reactivation of KSHV in conditions of hypoxia [4] . In this study we aimed to confirm the high prevalence of KSHV in the GPC in recent years, with higher antiretroviral therapy coverage, and determine the role of anemia and malaria coinfection as risk factors for KSHV prevalence and antibody levels in a highly endemic population.
METHODS

Study Population and Sociodemographic Data Collection
The GPC is located in south-western Uganda, in Kyamulibwa subcommunity of Kalungu district, with an altitude of approximately 1200 m above sea level. It is community-based open cohort of about 22 000 people in 25 adjacent villages [5] . This cross-sectional study analyzed plasma samples collected from 2 surveys, the adult survey and the children survey. The adults were surveyed in 2014/2015 and the children in 2016. Adults without hematological parameter data and children without either hematological parameter data or malaria parasitemia status data were excluded in the laboratory analysis. Children less than 1 year of age were excluded from the statistical analysis and children less than 2 years were not tested for HIV serostatus, due to the potential for maternal IgG to be present, which could affect antibody measurement. Socioeconomic scores were generated for adults using principal component analysis of various household indicators during the previous survey.
Ethical Approval
The study was approved by the Research and Ethics Committee Uganda Virus Research Institute and the Uganda National Council for Science and Technology.
Hematological and Serological Analysis
During these 2 surveys, blood was collected from study participants and tested immediately after collection for human immunodeficiency virus (HIV); a smaller proportion of samples were also tested for malaria parasitemia and hemoglobin levels, using point-of-care assays and rapid tests. HIV serostatus was determined using rapid diagnostic tests. Malaria parasitemia was measured in children only, using malaria Rapid Diagnostic Tests (One Step Malaria HRP-II [Pf] and pLDH [Pan] Antigen Rapid Test). Hemoglobin levels in g/dL were obtained from a Hemocue 201 analyzer.
Stored plasma samples for both children and adults were retrieved and tested for KSHV antibodies using an in-house enzyme-linked immunosorbent assay (ELISA), as previously described [6] . Samples from the 2 surveys were tested separately after simple randomization onto ELISA plates. Antibodies to both K8.1 and ORF73 proteins were measured as optical density. Each ELISA plate contained 3 negative and positive control wells; negative controls were used to calculate a cutoff value for every plate as previously described [2, 7] . Seropositivity was defined as reactivity to either K8.1 or ORF73 proteins.
Statistical Analysis
Statistical analysis was carried out using STATA13 (Statacorp, College Station, TX). Children's and adults' results were analyzed separately. Hemoglobin levels were mean centered for easier interpretation. Anemia was defined using hemoglobin levels in g/dL after altitude adjustment following World Health Organization (WHO) guidelines [8] . A constant value 0.5 was subtracted from hemoglobin levels for altitude adjustment, the results were then categorized into normal and anemic using the following cutoff values: 11.0 for pregnant females and children below 5 years, 11.5 for children 5 to 11 years, 12.0 for children 12 to 14 years and other females 15 years and above, and 13.0 for males 15 years and above. These WHO hemoglobin reference ranges used to define anemia may not be representative of African populations, as previously reported [9, 10] , because they are based on western population data. We therefore analyzed hemoglobin both as a continuous variable and as categorized into normal and anemic using separate regression models.
Linear regression with bootstrapped confidence intervals (CI) was used for antibody levels analysis, because they were severely skewed. Logistic regression was used for seroprevalence analysis; furthermore, we adjusted for clustering at the village level using survey commands. We assessed interaction between age and hemoglobin levels, as well as between age and anemia, in relation to anti-K8.1 antibody levels, anti-ORF73 antibody levels, and KSHV prevalence based on a priori suspicions of interaction, using likelihood ratio tests.
RESULTS
The characteristics of the individuals analyzed are shown in Supplementary Table 1. We analyzed results from 3149 adults and 4134 children. This analysis included children aged 1 to 17 years and adults aged 18 to 103 years (Supplementary Table 1 ).
Risk Factors for KSHV Prevalence and Antibody Levels Among Adults
KSHV prevalence was 91% in all adults (2871/3149) (Supplementary Figure 1) . Every 1 g/dL decrease in hemoglobin values was associated with increased odds of being KSHV seropositive (odds ratio [OR] = 0.86; 95% CI, 0.77-0.96; P = .006) and anemic individuals were more likely to be KSHV seropositive compared to people with normal hemoglobin values, but this association was not statistically significant (OR = 1.25; 95% CI, 0.87-1.79; P = .229; Table 1 ).
We then analyzed antibody levels to K8.1 and ORF73 proteins as continuous variables without categorizing participants as seropositive or seronegative. Anemic adults had higher antibodies to ORF73 protein compared to individuals with normal hemoglobin values (regression coefficient 0.28; 95% CI, 0.16-0.39; P < .0001). Similarly, every 1 g/dL decrease in hemoglobin was associated with an increase in ORF73 antibody optical densities ( Table 1) . The association between hemoglobin and antibodies to ORF73 protein was strongest among older people (Table 1) . Conversely, anti-K8.1 antibody levels were not significantly associated with either hemoglobin levels or anemia (Table 1 ). This may be due to the relative abundance of LANA compared to late lytic proteins such as K8.1, even during KS disease [11] .
Compared to HIV-negative adults, HIV-positive adults had lower antibodies to KSHV, especially those with CD4 counts of 500 cell/μL or less (Table 1) . This may be due to B-cell dysfunction caused by HIV infection, and consequent decreased antibody responses [12, 13] . On the other hand, HIV-positive adults with CD4 counts above 500 cells/μL, compared to HIVnegative adults, were more likely to be KSHV seropositive (Table 1) , which may be due to antiretroviral treatment.
Risk Factors for KSHV Prevalence and Antibody Levels Among Children
We then investigated associations between KSHV prevalence and antibody levels and risk factors among children. Overall, KSHV prevalence was 51% (2117/4134) in the children, the prevalence increased with age, rising from 31% among 1-5 year olds, to 53% among 6-12 year olds, to 73% among 13-17 year olds (Supplementary Figure 1) . We first adjusted for HIV status, age, and sex, then malaria parasitemia and anemia/hemoglobin levels were added in the full models. In the first analysis, hemoglobin levels, malaria parasitemia, and age were strongly associated with KSHV prevalence (Table 2) . Every 1 g/dL decrease in hemoglobin levels increased the odds of being KSHV seropositive by 11% (P < .0001) and the odds of being KSHV positive if anemic compared to normal hemoglobin levels was 1.42 (95% CI, 1.18-1.71; P < .0001). The odds of being KSHV seropositive, if malaria infected, compared to uninfected was 2.22 (95% CI, 1.84-2.69; P < .0001) and every annual increase in age was associated with a 17% increased risk of being KSHV seropositive (Table 2) .
After adjusting for malaria parasitemia, the risk of being KSHV seropositive for every 1 g/dL decrease in hemoglobin reduced to 7% (P = .005). Similarly, the odds of being KSHV seropositive in comparing anemic children to children with normal hemoglobin levels reduced to 1.23 (95% CI, 1.01-1.49; P = .037). After adjusting for hemoglobin levels, the odds of being KSHV seropositive comparing children with and without malaria parasitemia changed little (OR = 2.13; 95% CI, 1.75-2.58; P < .0001) ( Table 2 ). Every annual increase in age remained strongly associated with increased KSHV prevalence risk, OR = 1.18 (P < .0001) even after adjusting for malaria parasitemia and hemoglobin (Table 2) .
We then finally investigated associations between the same risk factors and KSHV antibody levels (optical density) as continuous variables without categorizing participants as seropositive or seronegative. Only malaria parasitemia was associated with both anti-K8.1 and anti-ORF73 antibody levels in the fully multivariate analysis ( Table 2) .
Discussion
We observed a significant association between hemoglobin levels and KSHV prevalence among children and adults, where people with low levels of hemoglobin were more likely to be Anti-K8.1 and anti-ORF73 antibody levels (measured as optical density) were obtained from enzyme-linked immunosorbent assay. KSHV seropositivity was defined as reactivity to either K8.1 or ORF73 antigens. Logistic regression, allowing for the survey design, was used for statistical analysis of risk factors for KSHV prevalence. Linear regression with bootstrapped confidence intervals was used for statistical analysis of risk factors for antibody levels. Age group specific associations between ORF73 antibody levels and hemoglobin levels were reported due to interaction between age and hemoglobin levels.
Abbreviations: Coef., regression coefficient; CI, confidence interval; KSHV, Kaposi sarcoma-associated herpesvirus; OR, odds ratio. Hemoglobin levels were mean (13.7 g/dL) centered.
c Hemoglobin levels were altitude adjusted and categorized into normal and anemic following World Health Organization guidelines.
KSHV seropositive. As a categorical variable, anemia was associated with KSHV prevalence among children. Reduction in hemoglobin has been shown to cause hypoxia/low tissue oxygen, while hypoxia has been shown to reactivate KSHV in vitro [4] . We therefore hypothesize that a low hemoglobin level leads to reactivation of KSHV through hypoxia. Increased reactivation may help spread the virus during initial infection. Alternately, hypoxia may enhance initial infection of cells, possibly through upregulation of the replication and transcription activator [14] .
In this cross-sectional study, we did not directly measure KSHV reactivation or KSHV viral load in blood or plasma, although antibody levels may be viewed as a surrogate marker for frequent reactivation. The connection between KSHV reactivation, hypoxia, and anemia requires further investigation. We showed that children infected with malaria are more likely to be KSHV seropositive. Additionally, the effect of anemia and/ or hemoglobin levels on KSHV prevalence and antibody levels reduced to about 50% after adjusting for malaria infection. Malaria causes anemia, and in part the anemia effect in children could be explained (confounded) by malaria infection. The consistent association between malaria infection and KSHV prevalence suggests malaria may be driving KSHV transmission in malaria endemic areas. This might imply that exposure to malaria significantly impacts on KSHV reactivation, which might also have long-lasting effects. The mechanism through which malaria may reactivate KSHV requires further investigation.
Findings from this study suggest malaria infection as a risk factor for KSHV prevalence. Malaria-associated anemia is one mechanism that likely contributes to this association but cannot entirely explain it. In KSHV and malaria endemic areas, a number of other parasite coinfections such as helminths, which cause anemia and/or immunomodulation are common. The role of multiple parasitic infections and KSHV transmission and pathogenesis warrants further careful study.
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